Model DetailsMammary gland adenocarcinoma
Model Name |
Mammary gland adenocarcinoma | Strain |
FVB;129S-Tg(C3-1-TAg)cJeg Trp53tm1Tyj/+ |
Tumor Inducing Agent(s) |
None (spontaneous) |
Tumor Synonyms |
mammary adenocarcinoma • mammary carcinoma • mammary gland tumor • mammary tumor |
Strain Synonyms |
FVB;129S-TgN(C3-1-TAg)cJeg Trp53tm1Tyj/+ • p53+/- TAG SV129/FVB-N • C3(1)/TAg+/-;p53+/- • C3(1)/TAG, p53+/- • TAG-/+, p53-/+ • C3(1)/TAg;p53+/- • p53+/- TAG |
| Organ Affected | Sex | Frequency | Age Of Detection | Additional Information Expand all Collapse all | Reference |
|---|---|---|---|---|---|
| Mammary gland | Female |
100% (8 of 8 mice) |
227 +/- 39 days |
|
Maroulakou IG, Mol Carcinog 1997 Oct;20(2):168-74 |
| Adrenal gland | Female |
observed |
227 +/- 39 days |
|
Maroulakou IG, Mol Carcinog 1997 Oct;20(2):168-74 |
| Liver | Female |
observed |
227 +/- 39 days |
|
Maroulakou IG, Mol Carcinog 1997 Oct;20(2):168-74 |
| Lung | Female |
observed |
227 +/- 39 days |
|
Maroulakou IG, Mol Carcinog 1997 Oct;20(2):168-74 |
| Lymph node | Female |
observed |
227 +/- 39 days |
|
Maroulakou IG, Mol Carcinog 1997 Oct;20(2):168-74 |
| (Unspecified organ) | Female |
87.5% (7 of 8 mice) |
227 +/- 39 days |
|
Maroulakou IG, Mol Carcinog 1997 Oct;20(2):168-74 |